NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
Ye Yang(Nanjing University of Chinese Medicine), Fenghuang Zhan(University of Applied Management Studies)
Cited by 72
Related Papers
Alternative splicing and cancer: a systematic review
|Signal Transduction and Targeted Therapy|2021|489
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance
|Oncotarget|2010|113
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
|Molecular Cancer|2021|72
BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability
|Signal Transduction and Targeted Therapy|2021|68
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies
|Journal of Clinical Investigation|2021|42